113 related articles for article (PubMed ID: 2244594)
21. RAS mutations are rare events in Philadelphia chromosome-negative/bcr gene rearrangement-negative chronic myelogenous leukemia, but are prevalent in chronic myelomonocytic leukemia.
Hirsch-Ginsberg C; LeMaistre AC; Kantarjian H; Talpaz M; Cork A; Freireich EJ; Trujillo JM; Lee MS; Stass SA
Blood; 1990 Sep; 76(6):1214-9. PubMed ID: 2205309
[TBL] [Abstract][Full Text] [Related]
22. A simple strategy for breakpoint fragment determination in chronic myeloid leukemia.
Kamel AM; Shaker HM; GadAllah FH; Hamza MR; Mansour O; El Hattab OH; Moussa HS
Cancer Genet Cytogenet; 2000 Oct; 122(2):110-5. PubMed ID: 11106820
[TBL] [Abstract][Full Text] [Related]
23. The breakpoint cluster region site in patients with Philadelphia chromosome-positive chronic myelogenous leukemia. Clinical, laboratory, and prognostic correlations.
Verschraegen CF; Kantarjian HM; Hirsch-Ginsberg C; Lee MS; O'Brien S; Rios MB; Stass SA; Keating M; Talpaz M
Cancer; 1995 Sep; 76(6):992-7. PubMed ID: 8625225
[TBL] [Abstract][Full Text] [Related]
24. A variant Philadelphia chromosome (Ph1) positive chronic myelocytic leukemia.
Haruta Y; Takahashi I; Sekito N; Miyamoto K; Shimamoto M; Wakita Y; Kikkawa K; Nakamura T; Seto T; Yamashita J
Acta Med Okayama; 1990 Oct; 44(5):283-6. PubMed ID: 2260501
[TBL] [Abstract][Full Text] [Related]
25. [Molecular study of Ph1 chromosome negative chronic myelocytic leukemia].
Chen S
Zhonghua Yi Xue Za Zhi; 1991 Aug; 71(8):425-7, 30. PubMed ID: 1660759
[TBL] [Abstract][Full Text] [Related]
26. BCR rearrangement-negative chronic myelogenous leukemia revisited.
Kurzrock R; Bueso-Ramos CE; Kantarjian H; Freireich E; Tucker SL; Siciliano M; Pilat S; Talpaz M
J Clin Oncol; 2001 Jun; 19(11):2915-26. PubMed ID: 11387365
[TBL] [Abstract][Full Text] [Related]
27. The site of the breakpoint within the bcr is a prognostic factor in Philadelphia-positive CML patients.
Mills KI; MacKenzie ED; Birnie GD
Blood; 1988 Oct; 72(4):1237-41. PubMed ID: 3167206
[TBL] [Abstract][Full Text] [Related]
28. Molecular and cytogenetic characterization of a novel translocation t(4;22) involving the breakpoint cluster region and platelet-derived growth factor receptor-alpha genes in a patient with atypical chronic myeloid leukemia.
Safley AM; Sebastian S; Collins TS; Tirado CA; Stenzel TT; Gong JZ; Goodman BK
Genes Chromosomes Cancer; 2004 May; 40(1):44-50. PubMed ID: 15034867
[TBL] [Abstract][Full Text] [Related]
29. A new chromosomal breakpoint in Ph positive, bcr negative chronic myelogenous leukemia. Report of a case.
Negrini M; Tallarico A; Pazzi I; Castagnoli A; Cuneo A; Castoldi GL
Cancer Genet Cytogenet; 1992 Jul; 61(1):11-3. PubMed ID: 1353407
[TBL] [Abstract][Full Text] [Related]
30. DNA sequence analysis of the major breakpoint cluster region of the BCR gene rearranged in Philadelphia-positive human leukemias.
Sowerby SJ; Kennedy MA; Fitzgerald PH; Morris CM
Oncogene; 1993 Jun; 8(6):1679-83. PubMed ID: 8502487
[TBL] [Abstract][Full Text] [Related]
31. Distribution of breakpoint within the breakpoint cluster region (bcr) in chronic myelogenous leukemia with a complex Philadelphia chromosome translocation.
Nishigaki H; Inazawa J; Misawa S; Nishida K; Okuda T; Horiike S; Tsuda S; Taniwaki M; Abe T
Am J Hematol; 1989 Nov; 32(3):194-9. PubMed ID: 2816913
[TBL] [Abstract][Full Text] [Related]
32. Studies of BCR and ABL gene rearrangements in chronic myelogenous leukemia patients by conventional and pulsed-field gel electrophoresis using gel inserts.
Jiang XY; Trujillo JM; Dao D; Liang JC
Cancer Genet Cytogenet; 1989 Oct; 42(2):287-94. PubMed ID: 2676142
[TBL] [Abstract][Full Text] [Related]
33. BCR breakpoint location and prognosis in CML.
Leibowitz D
Blood; 1989 May; 73(6):1745-6. PubMed ID: 2653462
[No Abstract] [Full Text] [Related]
34. Molecular diagnosis of chronic myeloid leukemia using a 3'bcr probe.
Berthéas MF; Vindimian M; Ollagnon G; Pomier G; Jaubert J; Vasselon C; Reynaud J; Heally JC; Le Petit JC; Brizard CP
Nouv Rev Fr Hematol (1978); 1989; 31(6):393-5. PubMed ID: 2616268
[TBL] [Abstract][Full Text] [Related]
35. Patterns of BCR/ABL gene rearrangements by interphase fluorescence in situ hybridization (FISH) in BCR/ABL+ leukemias: incidence and underlying genetic abnormalities.
Primo D; Tabernero MD; Rasillo A; Sayagués JM; Espinosa AB; Chillón MC; Garcia-Sanz R; Gutierrez N; Giralt M; Hagemeijer A; San Miguel JF; Orfao A
Leukemia; 2003 Jun; 17(6):1124-9. PubMed ID: 12764379
[TBL] [Abstract][Full Text] [Related]
36. Philadelphia-negative chronic myelogenous leukemia with breakpoint cluster region rearrangement: molecular analysis, clinical characteristics, and response to therapy.
Shtalrid M; Talpaz M; Blick M; Romero P; Kantarjian H; Taylor K; Trujillo J; Schachner J; Gutterman JU; Kurzrock R
J Clin Oncol; 1988 Oct; 6(10):1569-75. PubMed ID: 3171624
[TBL] [Abstract][Full Text] [Related]
37. Molecular cytogenetic characterization of deletions on der(9) in chronic myelocytic leukemia.
Zagaria A; Anelli L; Albano F; Vicari L; Schiavone EM; Annunziata M; Pane F; Liso V; Rocchi M; Specchia G
Cancer Genet Cytogenet; 2006 Jun; 167(2):97-102. PubMed ID: 16737907
[TBL] [Abstract][Full Text] [Related]
38. [The cellular and molecular-biological studies on Philadelphia chromosome-positive acute lymphocytic leukemia].
Kunieda Y
Hokkaido Igaku Zasshi; 1993 May; 68(3):337-49. PubMed ID: 8319933
[TBL] [Abstract][Full Text] [Related]
39. Influence of M-BCR breakpoint sites on the duration of chronic phase in 100 patients with chronic myelocytic leukemia.
Tanaka K; Hashimoto T; Oguma N; Dohy H; Kamada N
Cancer Genet Cytogenet; 1993 Oct; 70(1):39-47. PubMed ID: 8221611
[TBL] [Abstract][Full Text] [Related]
40. Breakpoint cluster region (BCR) gene rearrangement studies in chronic myeloid and acute lymphoblastic leukemias.
Chin YM; Bosco JJ; Koh CL
Med J Malaysia; 1992 Jun; 47(2):110-3. PubMed ID: 1494330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
